Clinical trial: A phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B

10.1111/j.1365-2036.2008.03686.x

Saved in:
Bibliographic Details
Main Authors: Lim, S.G., Leung, N., Hann, H.W.L., Lau, G.K.K., Trepo, C., Mommeja-Marin, H., Moxham, C., Sorbel, J., Snow, A., Blum, M.R., Rousseau, F., Marcellin, P.
Other Authors: MEDICINE
Format: Article
Published: 2011
Online Access:http://scholarbank.nus.edu.sg/handle/10635/26670
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-26670
record_format dspace
spelling sg-nus-scholar.10635-266702023-10-25T20:52:35Z Clinical trial: A phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B Lim, S.G. Leung, N. Hann, H.W.L. Lau, G.K.K. Trepo, C. Mommeja-Marin, H. Moxham, C. Sorbel, J. Snow, A. Blum, M.R. Rousseau, F. Marcellin, P. MEDICINE 10.1111/j.1365-2036.2008.03686.x Alimentary Pharmacology and Therapeutics 27 12 1282-1292 2011-09-27T05:14:24Z 2011-09-27T05:14:24Z 2008 Article Lim, S.G., Leung, N., Hann, H.W.L., Lau, G.K.K., Trepo, C., Mommeja-Marin, H., Moxham, C., Sorbel, J., Snow, A., Blum, M.R., Rousseau, F., Marcellin, P. (2008). Clinical trial: A phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B. Alimentary Pharmacology and Therapeutics 27 (12) : 1282-1292. ScholarBank@NUS Repository. https://doi.org/10.1111/j.1365-2036.2008.03686.x 02692813 13652036 http://scholarbank.nus.edu.sg/handle/10635/26670 000255931100013 Scopus
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
description 10.1111/j.1365-2036.2008.03686.x
author2 MEDICINE
author_facet MEDICINE
Lim, S.G.
Leung, N.
Hann, H.W.L.
Lau, G.K.K.
Trepo, C.
Mommeja-Marin, H.
Moxham, C.
Sorbel, J.
Snow, A.
Blum, M.R.
Rousseau, F.
Marcellin, P.
format Article
author Lim, S.G.
Leung, N.
Hann, H.W.L.
Lau, G.K.K.
Trepo, C.
Mommeja-Marin, H.
Moxham, C.
Sorbel, J.
Snow, A.
Blum, M.R.
Rousseau, F.
Marcellin, P.
spellingShingle Lim, S.G.
Leung, N.
Hann, H.W.L.
Lau, G.K.K.
Trepo, C.
Mommeja-Marin, H.
Moxham, C.
Sorbel, J.
Snow, A.
Blum, M.R.
Rousseau, F.
Marcellin, P.
Clinical trial: A phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B
author_sort Lim, S.G.
title Clinical trial: A phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B
title_short Clinical trial: A phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B
title_full Clinical trial: A phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B
title_fullStr Clinical trial: A phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B
title_full_unstemmed Clinical trial: A phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B
title_sort clinical trial: a phase ii, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis b
publishDate 2011
url http://scholarbank.nus.edu.sg/handle/10635/26670
_version_ 1781410511805480960